Ribociclib

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Sales Forecast of FDA’s New Drug Approvals of 2017

2017 was a landmark year for the pharmaceutical industries in the US and Europe, with a sharp increa

Axovant’s hyped Alzheimer’s drug fails trial as Pfizer emulates Axovant; Amneal and Impax in merger talks

This week in Phispers, we bring you news about intepirdine, Axovant’s experimental drug for Al